Estrogen and Bone Loss

Advances in Organ Biology

Volumn 5, Issue C, 1998, Pages 641-659

  Pacifici, Roberto ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000111333     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(08)60146-9     Document Type: Article

References (123)

1. Ammann P., Rizzoli R., Bonjour J.P., Bourrin S., Meyer J.M., Vassalli P., and Garcia I. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J. Clin. Invest. 99 (1997) 1699-1703
2. Arend W.P. Interleukin 1 receptor antagonist: A new member of the interleukin I family. J. Clin. Invest. 88 (1991) 1445-1451
3. Arend W.P., Joslin F.G., Thompson R.C., and Hannum C.H. An IL-1 inhibitor from human monocytes. J. Immunol. 143 (1989) 1851-1858
4. Bain S.D., Bailey S.C., Celino D.L., Lantry M.M., and Edwards M.W. High-dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse. J. Bone Min. Res. 8 (1993) 435-442
5. Bellido T., Girasole G., Passed G., Yu X.P., Mocharla A., Jilka R.L., Notides A., and Manolagas S.C. Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: Deregulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3. Endocrinology 133 (1993) 553-562
6. Bertolini D.R., Nedwin G.E., Bringman T.S., Smith D.D., and Mundy G.R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature 319 (1986) 516-518
7. Boyce B.F., Aufdemorte T.B., Garrett L.R., Yates A.J.P., and Mundy G.R. Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125 (1989) 1142-1150
8. Burger D., Chicheportiche R., Giri J.G., and Dayer J.M. The inhibitory activity of human interleukin-I receptor anatgonist is enhanced by type-11 interleukin-I soluble receptor and hindered by type-I interleukin-I soluble receptor. J. Clin. Invest. 96 (1995) 38-41
9. Canalis E. Interleukin-I has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae. Endocrinology 118 (1986) 74-81
10. Carter D.B., Deibel Jr. M.R., Dunn C.J.C.-S., Tomich C., Laborde A.L., Slightom J.L., Berger A.E., Bienkowski M.J., Sun F.F., McEwan R.N., Harris P.K.W., Yem A.W., Waszak G.A., Chosay J.G., Sieu L.C., Hardee M.M., Zurcher-Neely H.A., Reardon M., Heinrikson R.L., Truesdell S.E., Shelly J.A., Eessalu T.E., Taylor B.M., and Tracey D.E. Purification, cloning, expression, and biological characterization of an interleukin-I receptor antagonist protein. Nature 344 (1990) 633-638
11. Chaudhary L.R., Spelsberg T.C., and Riggs B.L. Production of various cytokines by normal human osteoblastlike cells in response to interleukin-1.9 and tumor necrosis factor-α: Lack of regulation by 17b,-estradiol. Endocrinology 130 2 (1992) 528-534
12. Cohen-Solal M.E., Graulet A.M., Guerris J., Denne M.A., Bergot C., Morieux C., Sedel L., Kuntz D., and de Vernejoul M.C. Bone resorption at the femoral neck is dependent on local factors in nonosteoporotic late postmenopausal women: An in vitro-in vivo study. J. Bone Min. Res. 10 (1995) 307-314
13. Chow J., Tobias J.H., Colston K.W., and Chambers T.J. Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J. Clin. Invest. 89 (1992) 74-78
14. Cohen-Solal M.E., Craulet A.M., Denne M.A., Gueris J., Baylink D., and de Vernejoul M.C. Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: Involvement of cytokines. J. Clin. Endocrinol. Metab. 77 (1993) 1648-1653
15. Cutolo M., Accardo S., Villaggio B., Clerico P., Bagnasco M., Coviello D.A., Carruba G., Lo Casto M., and Castagnetta L. Presence of estrogen-binding sites on macrophagelike synoviocytes and CD8+, CD29+, CD45RO+ T-lymphocytes in normal and rheumatoid synovium. Arthritis and Rheumatism 36 (1993) 1087-1097
16. Dinarello C.A. Biology of interleukin 1. FASEB 2 (1988) 108-115
17. Dinarello C.A. Interleukin-I and its biologically related cytokines. Adv. Immunol. 44 (1989) 153-205
18. Dinarello C.A. Interleukin-I and Interleukin-1 antagonism. Blood 777 (1991) 1627-1652
19. Dinarello C.A. The biological properties of interleukin-1. Eur. Cytokine Netw. 5 (1994) 517-531
20. Elias J.A., and Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J. Immunol. 145 (1990) 161-166
21. Eriksen E.F., Colvard D.S., Berg N.J., Graham M.L., Mann K.G., Spelsberg T.C., and Riggs B.L. Evidence of estrogen receptors in normal human osteoblastlike cells. Science 241 (1988) 84-86
22. Ettinger B., Genant H.K., and Cann E.C. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann. Intern. Med. 102 (1985) 319-324
23. Felix R., Fleish H., and Elford P.R. Bone-resorbing cytokines enhance release of macrophage colony-stimulating activity by osteoblastic cell MC3T3-E1. Calcif Tissue. Int. 44 (1989) 356-360
24. Felix R., Cecchini M.G., and Fleish H. Macrophage colony-stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127 (1990) 2592-2597
25. Fibbe W.E., Van Damme J., Billiau A., Goselink H.M., Vogt P.J., Van Eeden P.R., Altroch B.W., and Falkenburg J.H.F. Interleukin-I induces human marrow stromal cells in long-term culture to produce G-CSF and M-CSF. Blood 71 (1988) 431-435
26. Fiore C.E., Falcidia E., Foti R., Motta M., and Tamburino C. Differences in the time course of the effects of oophorectomy in women on parameters of bone metabolism and Interleukin-I levels in the circulation. Bone Miner. 20 (1993) 79-85
27. Gallagher J.C., Riggs B.L., and DeLuca H.F. Effect of estrogen on calcium absorption and serum vitamin D metabolites in post-menopausal osteoporosis. J. Clin. Endocrinol. Metab. 51 (1980) 1359-1364
28. Genant H.K., Cann C.E., Ettinger B., and Gordan G.S. Quantitative computed bone tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Ann. Intern. Med. 97 (1982) 699-705
29. Girasole G., Pedrazzoni M., Giuliani N., Passed G., and Passed M. Increased serum soluble interleukin-6 receptors levels are induced by ovariectomy, prevented by estrogen replacement and reversed by alendronate administration. J. Bone Miner. Res. 10 (1995) A86
30. Girasole G., Jilka R.L., Passed G., Boswell S., Boder G., Williams D.C., and Manolagas S.C. 17ß-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 89 (1992) 883-891
31. Gowen M., Wood D.D., and Russell R.G.G. Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-I activity. J. Clin. Invest. 75 (1985) 1223-1229
32. Gowen M., Wood D.D., Ihrie E.J., McGuire M.K.B., and Russell R.G.G. An interleukin-1-like factor stimulates bone resorption in vitro. Nature 306 (1983) 378-380
33. Gulshan S., McCruden A.B., and Stimson W.H. Estrogen receptor in macrophages. Scan. J. Immunol. 31 (1990) 691-697
34. Hannum C.H., Wflcox C.J., Arend W.P., Joslin F.G., Dripps D.J., Heftndal P.L., Armes L.G., Sommer A., Eisenberg S.P., and Thompson R.C. Interleukin-I receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343 (1990) 336-340
35. Hansen M.B., Svenson M., and Bendtzen K. Human anti-interleukin la antibodies. Immunol. Lett. 30 (1990) 133-140
36. Heaney R.P., Recker R.R., and Saville P.D. Menopausal changes in bone remodelling. J. Lab. Clin. Med. 92 (1978) 964-970
37. Horowitz M. Cytokines and estrogen in bone: Antiosteoporotic effects. Science 260 (1993) 626-627
38. Horsman A., Jones M., Francis R., and Nordin B.E.C. The effect of estrogen dose on postmenopausal bone loss. New. Eng. J. Med. 309 (1983) 1405-1407
39. Hughes D.E., Jilka R.L., Manolagas S., Dallas S.L., Bonewald L.F., Mundy G.R., and Boyce B.F. Sex steroids promote osteoclast apoptosis in vitro and in vivo. J. Bone Miner. Res. 10 (1995) 48 Abstract.
40. Hustmyer F.G., Walker E., Yu X.P., Girasole G., Sakagami Y., Peacock M., and Manolagas S.C. Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J. Bone Miner. Res. 8 (1993) 51-59
41. Hynes R.O. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69 (1992) 11-25
42. Jilka R.L., Hangoc G., Girasole G., Passeri G., Williams D.C., Abrams J.S., Boyce B., Broxmeyer H., and Manol'agas S.C. Increased osteoclast development after estrogen loss: Mediation by Interleukin-6. Science 257 (1992) 88-91
43. Johnson R.A., Boyce B.F., Mundy G.R., and Roodman G.D. Tumors producing human tumor necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology 124 (1989) 1424-1427
44. Johnston Jr. C.C., Hui S.L., Witt R.M., Appledorn R., Baker R.S., and Longcope C. Early menopausal changes in bone mass and sex steroids. J. Clin. Endocrinol. Metab. 61 (1985) 905-911
45. Kaneki M., Nakamura T., Masuyama A., Chen J.T., Seimiya Y., Shiraki M., Ouchi Y., and Orimo H. The effect of menopause on IL-1 and IL-6 release from peripheral blood monocytes. J. Bone Miner. Res. 6 (1991) 76 (Abstract.)
46. Khosla S., Peterson J.M., Egan K., Jones J.D., and Riggs L.B. Circulating cytokine levels in osteoporotic and normal women. J. Clin. Endocrinol. Metab. 79 (1994) 707-711
47. Kimble R.B., Matayoshi A.B., Vannice J.L., and Pacifici R. Long-term treatment with IL-1 receptor antagonist (IL-Ira) blocks bone loss in ovariectomized rats. J. Bone Min. Res. (1994) 9 (Abstract; In press.)
48. Kimble R.B., Matayoshi A.B., Vannice J.L., Kung V.T., Williams C., and Pacifici R. Simultaneous block of Interleukin I and tumor necrosis factor is required to completely prevent bone loss in the early post-ovariectomy period. Endocrinology 136 (1995) 3054-3061
49. Kimble R.B.S., Srivastava S., Bellone C.J., and Pacifici R. Estrogen inhibits IL1 TNF gene expression in transfected murine macrophagic cells. J. Bone Min. Res. 11 Suppl. l (1996) 235 (Abstract.)
50. Kimble R.B., Vannice J.L., Brownfield C., and Pacifici R. Persistent bone-sparing effect of interleukin-I receptor antagonist: A hypothesis on the role of IL-1 in ovariectomy-induced bone loss. Calcif Tissue Int. 55 (1994) 260-265
51. Kimble R.B., Vannice J.L., Bloedow D.C., Thompson R.C., Hopfer W., Kung V., Brownfield C., and Pacifici R. Interleukin-I receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J. Clin. Invest. 93 (1994) 1959-1967
52. Kimble R., Bain S.D., and Pacifici R. The functional block of TMF but not of IL-6 prevent bone loss in ovariectomized mice. J. Bone Miner. Res. 12 (1997) 935-941
53. Kitazawa R., Kimble R.B., Vannice J.L., Kung V.T., and Pacifici R. Interleukin-I receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. Clin. Invest. 94 (1994) 2397-2406
54. Komm B.S., Terpening C.M., Benz D.J., Graeme K.A., Gallegos A., Korc M., Greene G.L., O'Mafly B.W., and Haussler M.R. Estrogen-binding, receptor mRNA and biologic response in osteoblastlike osteosarcoma cells. Science 241 (1988) 81-83
55. Kurihara N., Chenu C., Miller M., Civin C., and Roodman G.D. Identification of committed mononuclear precursors for osteoclastlike cells formed in long-term human marrow cultures. Endocrinology 126 (1990) 2733-2741
56. Kurihara N., Civin C., and Roodman G.D. Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J. Bone. Miner. Res. 6 (1991) 257-261
57. Kurihara N., Suda T., Miura Y., Nakauchi H., Kodama H., Hiura K., Hakeda Y., and Kumegawa M. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 74 (1989) 1295-1302
58. Lindsay R., Hart D.M., Forrest C., and Baird C. Prevention of spinal osteoporosis in oophorectomized women. Lancet 2 (1980) 1151-1154
59. Lorenzo J.A., Sousa S.L., Alander C., Raisz L.G., and Dinarello C.A. Comparison of the bone-resorbing activity in the supernatants from phytohemaglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology 121 (1987) 1164-1170
60. Lorenzo J.A., Souss S.L., Fonseca J.M., Hock J.M., and Medlock E.S. Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro. J. Clin. Invest. 160 (1987) 160-164
61. Lowik C.W.G.M., Van derPlujim G., Bloys H., Hoekeman K., Bijvoet O.L.M., Aarden L.A., and Papapoulos S.E. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate IL-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogensis. Biochem. Biophys. Res. Commun. 162 (1993) 1546-1552
62. Macdonald B.R., Mundy G.R., Clark S., Wang E.A., Kuehl T.J., Stanley E.R., and Roodman G.D. Effects of human recombinant CSF-GM and highly purified CSF-I on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J. Bone Miner. Res. 1 (1986) 227-232
63. Matayoshi A., Brown C., DiPersio J., Haugh J., Kuestner R., and Pacifici R. Generation of human osteoclasts from peripheral blood CD34+ Cells. J. Bone Miner. Res. 10 (1995) T298 (Abstract.)
64. Matsuda T., Matsui K., Shimakoshi Y., Aida Y., and Hukuda S. 1-Hydroxyethilidene-1,1-bisphosphonate decreases the postovariectomy-enhanced interleukin 1 production by peritoneal macrophages in adult rats. Calcif Tissue. Int. 49 (1991) 403-406
65. McKane R., Khosla S., Peterson J., Egan K., and Riggs B.L. Effect of age and menopause on serum Interleukin-1.9 and Intereleukin-6-levels in women. J. Bone Miner. Res. 8 (1993) 162A
66. Miyaura C., Kusano K., Masuzawa T., Chaki O., Onoe Y., Aoyagi M., Sasaki T., Tamura T., Koishihara Y., Ohsugi Y., and Suda T. Endogenous bone-resorbing factors in estrogen deficiency cooperative effects of IL-1 and IL-6. J. Bone Miner. Res. 10 (1995) 1365-1373
67. Most W., Beek E.V., Ruwhof C., Berzooijen R.V., Aderveen A., Kopf M., Papapoulos S., and Lowik C. Osteoclastic resorption in interleukin-6-deficient mice. J. Bone Miner. Res. 9 (1994) 48 (Abstract.)
68. Nguyen L., Dewhirst F.E., Hauschka P.V., and Stashenko P. Interleukin-IF, stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res. 10 (1991) 15-21
69. Nilas L., and Christiansen C. Bone mass and its relationship to age and the menopause. J. Clin. Endocrinol. Metab. 65 (1987) 697-702
70. Ohta H., Makita K., Suda Y., Ikeda T., Masuzawa T., and Nozawa S. Influence of oophorectomy on serum levels of sex steroids and bone metabolism and assessment of bone mineral density in lumbar trabecular bone by QCT-C value. J. Bone Min. Res. 7 (1992) 659-665
71. Ohta H., Ikeda T., Masuzawa T., Makita K., Suda Y., and Nozawa S. Differences in axial bone mineral density, serum levels of sex steroids, and bone metabolism between postmenopausal and age- and body size-matched premenopausal subjects. Bone 14 (1993) 111-116
72. Oursler M.J. Osteoclast synthesis and secretion and activation of latent transforming growth factor ß. J: Bone Miner. Res. 9 (1994) 443-452
73. Oursler M.J., Cortese C., Keeting P., Anderson M.A., Bonde S.K., Riggs B.L., and Spelsberg T.C. Modulation of transforming growth factor-ß production in normal human osteoblastlike cells by 17ß-estradiol and parathyroid hormone. Endocrinology 129 (1991) 3313-3320
74. Oursler M.J., Pederson L., Pyfferoen J., Osdoby P., Fitzpatrick L., and Spelsberg T.C. Estrogen modulation of avian osteoclast lysosomal gene expression. Endocrinology 132 (1993) 1373-1380
75. Oursler M.J., Osdoby P., Pyfferoen J., Riggs B.L., and Spelsberg T.C. Avian osteoclasts as estrogen target cells. Proc. Natl. Acad. Sci. USA 88 (1991) 6613-6617
76. Pacifici R., Carano A., Santoro S.A., Rifas L., Jeffrey J.J., Malone J.D., McCracken R., and Avioli L.V. Bone matrix constituents stimulate interleukin-I release from human blood mononuclear cells. J. Clin. Invest. 87 (1991) 221-228
77. Pacifici R., Basilico C., Roman J., Zutter M.M., Santoro S.A., and McCracken R. Collagen-induced release of interleukin 1 from human blood mononuclear cells. Potentiation by fibronectin binding to the α5 ß1 integrin. J. Clin. Invest. 89 (1992) 61-67
78. Pacifici R., Brown C., Puscheck E., Friedrich E., Slatopolsky E., Maggio D., McCracken R., and Avioli L.V. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Nat. Acad. Sci. USA 88 (1991) 5134-5138
79. Pacifici R., Brown C., Rifas L., and Avioli L.V. TNFCa and GM-CSF secretion from human blood monocytes: Effect of menopause and estrogen replacement. J. Bone Miner. Res. 5 (1990) 181 (Abstract.)
80. Pacifici R., Vannice J.L., Rifas L., and Kimble R.B. Monocytic secretion of interleukin-I receptor antagonist in normal and osteoporotic women: Effect of menopause and estrogen/progesterone therapy. J. Clin. Endocrinol. Metab. 77 (1993) 1135-1141
81. Pacifici R., Rifas L., McCracken R., Vered L., McMurtry C., Avioli L.V., and Peck W.A. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin I release. Proc. Natl. Acad. Sci. USA 86 (1989) 2398-2402
82. Pacifici R., Rifas L., Teitelbaum S., Slatopolsky E., McCracken R., Bergfeld M., Lee W., Avioli L.V., and Peck W.A. Spontaneous release of interleukin I from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc. Natl. Acad. Sci. USA 84 (1987) 4616-4620
83. Passeri G., Girasole G., Jilka R.L., and Manolagas S.C. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 133 (1993) 822-828
84. Pfeilschifter J., Chenu C., Bird A., Mundy G.R., and Roodman G.D. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J. Bone Miner. Res. 4 (1989) 113-118
85. Pioli G., Basini G., Pedrazzoni M., Musetti G., Ulietti V., Bresciani D., Villa P., Bacci A., Hughes D., Russell G., and Passeri M. Spontaneous release of Interleukin-I and interleukin-6 by peripheral blood monocytes after ovariectomy. Clin. Scien. 83 (1992) 503-507
86. Pioli G., Girasole G., Pedrazzoni M., Sansoni P., Davoli L., Ciotti G., Mantovani A., and Passeri M. Spontaneous release of Interleukin I (IL-1) from medullary mononuclear cells of Pagetic subjects. Calcif Tissue. Int. 45 (1989) 257-259
87. Polan M.L., Loukides J., Nelson P., Carding S., Diamond M., Walsh A., and Bottomly K. Progesterone and estradiol modulate interleukin-1]R messenger ribonucleic acid levels in cultured human peripheral monocytes. J. Clin. Endocrinol. Metab. 69 (1989) 1200-1206
88. Poli V., Balena R., Fattori E., Markatos A., Yamamoto M., Tanaka H., Ciliberto G., Rodan G.A., and Costantini F. Interleukin-6-deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13 (1994) 1189-1196
89. Pottratz S.T., Bellido T., Mocharia H., Crabb D., and Manolagas S. 17ß,-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J. Clin. Invest. 93 (1994) 944-950
90. Prince R.L. Counterpoint: Estrogen effects on calcitropic hormones and calcium homeostasis. (Review.). Endocr. Rev. 15 (1994) 301-309
91. Raisz L.G. Local and systemic factors in the pathogenesis of osteoporosis. N. Eng. J. Med. 318 (1988) 818-828
92. Ralston S.H. Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis. J. Bone Miner. Res. 9 (1994) 883-890
93. Ralston S.H., Russell R.G.G., and Gowen M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J. Bone Miner. Res. 5 (1990) 983-988
94. Ray A., Prefontaine K.E., and Ray P. Downmodulation of interleukin-6 gene expression by 17ß-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J. Biol. Chem. 269 (1994) 12940-12946
95. Rickard D., Russell G., and Gowen M. Oestradiol inhibits the release of tumour necrosis factor but not interleukin 6 from adult human osteoblasts in vitro. Osteoporosis Int. 2 (1992) 94-102
96. Rifas L., Kenney J.S., Marcelli M., Pacifici R., Dawson L.L., Cheng S., and Avioli L.V. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: Evidence that induction by interleukin-I and tumor necrosis factor-α is not regulated by ovarian steroids. Endocrinology 136 (1995) 4056-4067 (Abstract.)
97. Riggs B., and Land Melton L.J. Medical progress: Involutional osteoporosis. New Eng J. Med. 314 (1986) 1676-1684
98. Riggs B.L., and Melton L.J. Evidence for two distinct syndromes of involutional osteoporosis. Am. J. Med. 75 (1986) 899-901
99. Riggs B.L., Wahner H.W., Dunn W.L., Mazess R.B., Offord K.P., and Melton L.J. Differential changes in bone mineral density of the appendicular and the axial skeleton with aging. J. Clin. Invest. 67 (1981) 328-335
100. Riggs B.L., Jowsey J., Goldsmith S., Kelly P.J., Hoffman D.L., and Arnaud C.C. Short- and long-term effects of estrogen and synthetic anabolic hormones in postmenopausal osteoporosis. J. Clin. Invest. 51 (1972) 1649-1663
101. Roodman G.D. Interleukin-6: An osteotropic factor? J. Bone Miner. Res. 7 (1992) 475-478
102. Routtenberg A. Knockout mouse fault lines [letter]. Nature 374 (1995) 314-315
103. Sabatini M., Boyce B., Aufdemorte T., Bonewald L., and Mundy G.R. Infusions of recombinant human interleukin-1α and -1ß cause hypercalcemia in normal mice. Proc. Nat. Acad. Sci. USA 85 (1988) 5235-5239
104. Schneider G.B., and Relfson M. Pluripotent hemopoietic stem cells give rise to osteoclasts in vitro: Effect of RGM-CSF. Bone. Min. 5 (1989) 129-138
105. Seckinger P., Klein-Nulend J., Alander C., Thompson R.C., Dayer J.-M., and Raisz L.G. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. J. Immunol. 145 (1990) 4181-4184
106. Simon J.A., Eastgate J.A., and Duff G.W. A soluble binding protein specific for interleukin IF, is produced by activated mononuclear cells. Cytokine 2 (1990) 190-198
107. Slemenda C., Hui S.L., Longcope C., and Johnston C.C. Sex steroids and bone mass. A study of changes about the time of menopause. J. Clin. Invest. 80 (1987) 261-1269
108. Srivastava S., McHugh K., Kimble R., Ross F.P., and Pacifici R. Estrogen down regulates the expression of M-CSF mRNA in bone marrow stromal cells by stimulating the production of the transcription factor EGR-1. J. Bone Miner. Res. 10 Suppl. 1 (1995) S18
109. Stashenko P., Dewhirst F.E., Rooney M.L., Desjardins L.A., and Heeley J.D. Interleukin-1F is a potent inhibitor of bone formation in vitro. J. Bone Miner. Res. 2 (1987) 559-565
110. Stein B., and Yang M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NFκB and C/EBP-ß Mol. Cell. Biol. 15 (1995) 4971-4979
111. Stock J.L., Coderre J.A., and Mallette L.E. Effects of a short course of estrogen on mineral metabolism in postmenopausal women. J. Clin. Endocrinol. Metab. 61 (1985) 595-600
112. Suda T., Takahashi N., and Martin T.J. Modulation of osteoclast differentiation. Endocr. Rev. 13 (1992) 66-80
113. Symons J.A., Young P.R., and Duff G.W. Soluble type-il interleukin-1 (il-1) receptor binds and blocks processing of il-1-ß precursor and loses affinity for il-1 receptor antagonist. Proc. Nat. Acad. Sci. USA 92 (1995) 1714-1718
114. Takahashi N., Udagawa N., Akatsu T., Tanaka H., Shionome M., and Suda T. Role of colony-stimulating factors in osteoclast development. J. Bone Miner. Res. 6 (1991) 977-985
115. Tanaka S., Takahashi N., Udagawa N., Tamura T., Akatsu T., Stanley E.R., Kurokawa T., and Suda T. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J. Clin. Invest. 91 (1993) 257-263
116. Thompson R.C., Dripps D.J., and Eisenberg S.P. IL-Ira: properties and uses of an interleukin-1 receptor antagonist. Agents Actions Supp. 35 (1991) 41-49
117. Thomson B.M., Mundy G.R., and Chambers T.J. Tumor necrosis factor α and F, induce osteoblastic cells to stimulate osteoclastic bone resorption. J. Immunol. 138 (1987) 775-779
118. Thomson B.M., Saklatvala J., and Chambers T.J. Osteoblasts mediate interleukin I stimulation of bone resorption by rat osteoclasts. J. Exp. Med. 164 (1986) 104-112
119. Tiegs R.D., Body J.J., Wahner H.W., Barta J., Riggs B.L., and Heath H.I. Calcitonin secretion in postmenopausal osteoporosis. N. Eng. J. Med. 312 (1985) 1097-1101
120. Weusten J.J., Blankenstein M.A., Gmelig-Meyling F.H., Schuurman H.J., Kater L., and Thijssen J.H. Presence of estrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinol. 112 (1986) 409-414
121. Wronski T.J., Dann L.M., Qi H., and Yen C.F. Skeletal effects of withdrawal of oestrogen and diphosphonate treatment in ovariectomized rats. Calcif. Tissue Int. 53 (1993) 210-216
122. Yoshida U.S., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., Sudo T., and Schultz L.D. The murine mutation osteopetrosis is in the coding region of macrophage colony stimulating factor gene. Nature 345 (1990) 442-444
123. Zarrabeitia M.T., Riancho J.A., Amado J.A., Napal J., and Gonzales-Macias J. Cytokine production by blood cells in postmenopausal osteoporosis. Bone Miner. 14 (1991) 161-167